SCHEMBL7208912

SCHEMBL7208912

O=C(NC(C(=O)Cl)C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
HPGD P15428 3/20 0.50
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
TSHR P16473 2/20 0.47
HTT P42858 1/20 0.47
SLC1A2 P43004 1/20 0.46
POLB P06746 1/20 0.45
HDAC3 O15379 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
IDO1 P14902 1/20 0.45
ALOX15 P16050 1/20 0.45
HDAC1 Q13547 1/20 0.45
CA9 Q16790 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5708283 0.82 SLC1A2 (0.58) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL27763275 0.77 KMT2A (0.44) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL27244159 0.77 LMNA (0.58) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL28274372 0.77 LMNA (0.58) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL20340201 0.76 TDP1 (0.48) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL5137955 0.76 TDP1 (0.48) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL4689548 0.76 SMN1; SMN2 (0.53) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL28458590 0.76 SLC1A2 (0.51) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL14128517 0.76 SLC1A2 (0.56) LMNAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL4689551 0.76 SMN1; SMN2 (0.53) LMNAHPGDALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030072740-A1 Pulmonary delivery of active agents EMISPHERE TECHNOLOGIES, INC. 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030072740-A1 Pulmonary delivery of active agents ANXA11, ANXA1, PIGS LMNA 1649/4885HPGD 1201/4885ALDH1A1 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.